A new study published in The American Journal of Medicine finds marijuana smokers have better insulin control and smaller waists. MSNBC’s Lawrence O’Donnell discusses the study with Dr. Murray Mittleman of the Harvard School of Public Health, one of the co-authors of the study.
In Mika Brzezinski's latest book "Obsessed," Sen. Claire McCaskill, D-Mo., tells her story of a life-changing moment where she knew she needed to improve her physical health. Sen. McCaskill joins Morning Joe to discuss her weight-loss journey.
COPENHAGEN (Reuters) - Denmark's Novo Nordisk could see the U.S. launch of its biggest drug hope, a new long-acting insulin, delayed until 2018 while it conducts more tests to satisfy regulators, it said on Wednesday. Full story
Scientists have identified a hormone that can sharply boost the number of cells that make insulin in mice, a discovery that may someday lead to a treatment for the most common type of diabetes. Full story
A new study says Hispanics are more likely to store fat in their pancreas, but less likely to be able to produce more insulin to compensate for this excess fat, putting them at higher risk for type 2 diabetes. KVEO's Michael Lopez reports.
Naomi Wyatt of the Camden Coalition of Health Care Providers joins The Dylan Ratigan Show to talk about hot-spotting in health care.
A promising study funded by the National Institutes of Health found that a spritz of insulin may improve memory in Alzheimer’s patients. NBC’s Robert Bazell has more.
Researchers are working on creating an artificial pancreas that would monitor blood levels and administer insulin. WNYT's Benita Zahn has the report.
Doctors say they've had remarkable results in a study to reverse the effects of Type 2 diabetes, with research indicating that a very low-calorie diet could help the body produce its own insulin. ITN’s Katy Fawcett reports.
A diabetic patient displays her insulin supplies and blood sugar level-testing device at the J.W.C.H. safety-net clinic in the center of skid row in downtown Los Angeles, July 30, 2007. REUTERS/Lucy Nicholson
An employee works on a Novo Nordisk production line for the new long-acting insulin Tresiba drug, in this August 18, 2012 handout picture provided by Novo Nordisk. U.S. regulators on February 10, 2013 dealt a major blow to Novo Nordisk's hopes for its new long-acting insulin Tresiba by demanding the
The new long-acting insulin Tresiba drug is seen on a Novo Nordisk production line, in this 2012 handout picture provided by Novo Nordisk. U.S. regulators on February 10, 2013 dealt a major blow to Novo Nordisk's hopes for its new long-acting insulin Tresiba by demanding the Danish drugmaker conduct